Structure Therapeutics Inc. American depositary receipts dropped 40% premarket on Monday after the company released new data from a study of GSBR-1290, its.
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 50 points on Monday. The Dow traded up 0.14% to 37,356.29 while the NASDAQ rose 0.25% to 14,851.19. The S&P 500 also rose, gaining, 0.37% to 4,736.45.
Structure Therapeutics shares tumbled 48% in recent Monday trading after on Interim efficacy results on GSBR-1290 show that at week eight, participants in the obesity cohort achieved a.
Structure Therapeutics Inc. (GPCR) shares are falling more than 51 percent on Monday morning trade, on reports that its weight loss and diabetes drug GSBR-1290's performance was weaker than its rival Eli Lilly's orforglipron at eight weeks.